[1] Xu H, Zhu Y, Niu X, et al. A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts[J]. Clinical Oncology. 2022.

[2] Cheng Y, Qin S K, Li J, Zhu Y, et al. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)[J]. Journal of Cancer Research and Clinical Oncology. 2021.

[3] Liu Y, Zhu Y, Cai M, et al. A Preliminary Study on the Establishment of the PDTX Model[J]. Cancer Management and Research. 2020, 12: 1969.

[4] 谢剑邦，王乾，陈亮亮，等. 基因分型对消化系统肿瘤FOLFOX方案和阿帕替尼药物敏感性的预测价值[J]. 临床肿瘤学杂志. 2020, 25(12): 6.

[5] Yang W, Meng Y, Zhu Y, et al. Establishment of the PDTX model of gynecological tumors[J]. American journal of translational research. 2019, 11(6): 3779.

[6] 周勇，何晓峰，朱燕萍，等. 人源肿瘤异种移植 (PDTX) 模型建立及药效学检测初步探讨[J]. 中国胸心血管外科临床杂志. 2018, 25(9): 804-808.

[7] Zhuang Y, Zhu Y, Wang H, et al. Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy[J]. Brazilian Journal of Medical and Biological Research. 2017, 50.